Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Harvard Business School
Medtronic
QuintilesIMS
Julphar
Cerilliant
Daiichi Sankyo
Moodys
Fish and Richardson

Generated: April 23, 2018

DrugPatentWatch Database Preview

ESGIC Drug Profile

« Back to Dashboard

Which patents cover Esgic, and what generic alternatives are available?

Esgic is a drug marketed by Forest Pharms and Mikart and is included in three NDAs.

The generic ingredient in ESGIC is acetaminophen; butalbital; caffeine. There are sixty-six drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine profile page.
Summary for ESGIC
Drug patent expirations by year for ESGIC

US Patents and Regulatory Information for ESGIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Forest Pharms ESGIC acetaminophen; butalbital; caffeine TABLET;ORAL 089660-001 Dec 23, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mikart ESGIC-PLUS acetaminophen; butalbital; caffeine CAPSULE;ORAL 040085-001 Mar 28, 1996 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mikart ESGIC-PLUS acetaminophen; butalbital; caffeine TABLET;ORAL 089451-001 May 23, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Cerilliant
Federal Trade Commission
Teva
Cantor Fitzgerald
Argus Health
Harvard Business School
Express Scripts
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.